Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Result of AGM

2 Sep 2025 13:40

RNS Number : 6968X
Severfield PLC
02 September 2025
 

SEVERFIELD PLC

Results of Annual General Meeting 2025

At the Company's Annual General Meeting held at 10 am today, 2 September 2025, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed will be submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at Financial Conduct Authority website (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

In Favour

Against

Total

Withheld

Resolution

No of votes

% of votes

No of votes

% of votes

No of votes

No of votes

1. To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 29 March 2025 together with the report of the auditor thereon.

192,101,898

99.31

1,337,154

0.69

193,439,052

145,067

2. To approve the Directors' remuneration report (other than the part containing the Directors' remuneration policy) for the financial year ended 29 March 2025 as set out in the Annual Report and Accounts 2025.

191,412,046

98.92

2,092,157

1.08

193,504,203

79,916

3. To approve the Directors' remuneration policy as set out in the Annual Report and Accounts 2025

190,980,497

98.70

2,506,011

1.30

193,486,508

97,611

4. To reappoint Adam Semple as a Director

191,908,006

99.16

1,616,278

0.84

193,524,284

59,835

5. To reappoint Charlie Cornish as a Director.

185,821,171

96.19

7,353,113

3.81

193,174,284

409,835

6. To reappoint Mark Pegler as a Director.

190,309,160

98.34

3,215,124

1.66

193,524,284

59,835

7. To appoint Cynthia Gordon as a Director

191,538,819

98.97

1,985,465

1.03

193,524,284

59,835

8. To appoint Janice Crawford as a Director

192,003,465

99.21

1,520,819

0.79

193,524,284

59,835

9. To appoint Ian McAulay as a Director

191,979,344

99.20

1,544,940

0.80

193,524,284

59,835

10. To reappoint KPMG LLP as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2026.

191,986,325

99.22

1,513,808

0.78

193,500,133

83,986

11. To authorise the Directors to determine the auditor's remuneration.

191,747,400

99.10

1,749,433

0.90

193,496,833

87,286

12. To authorise the Directors to allot securities of the Company.

191,933,326

99.17

1,608,999

0.83

193,542,325

41,794

13. To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company.

191,268,786

99.01

1,919,568

0.99

193,188,354

395,765

14. To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or specified capital investment.

191,254,774

99.00

1,933,580

1.00

193,188,354

395,765

15. To authorise the Company to make market purchases of the Company's ordinary shares.

192,153,662

99.28

1,388,329

0.72

193,541,991

42,128

16. That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice.

191,888,938

99.14

1,658,886

0.86

193,547,824

36,295

 

 

Mark Sanderson

Company Secretary 2nd September 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFZGGLZZVGKZM
Date   Source Headline
2nd Jun 202612:08 pmRNSVoting Rights and Share Capital Update
31st Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSAppointment of Chief Financial Officer
29th Jan 20262:45 pmRNSStrategic Review of the Modular Solutions Business
2nd Dec 20257:00 amRNSInterim Results
1st Dec 20253:54 pmRNSTotal Voting Rights
31st Oct 202510:33 amRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSNotification of CEO Start Date & Notice of Results
3rd Oct 202510:16 amRNSHolding(s) in Company
23rd Sep 202511:11 amRNSAppointment of Interim Chief Financial Officer
11th Sep 20257:00 amRNSDirectorate Change
2nd Sep 20251:40 pmRNSResult of AGM
2nd Sep 20257:00 amRNSAGM trading update
13th Aug 20257:00 amRNSAppointment of Chief Executive Officer
29th Jul 20254:01 pmRNSDirector/PDMR Shareholding
29th Jul 202511:30 amRNSDirector/PDMR Shareholding
24th Jul 20257:43 amRNS-RProgressive publishes new research
24th Jul 20257:00 amRNSFinal Results
22nd Jul 20253:27 pmRNSHolding(s) in Company
18th Jul 20251:23 pmRNSJSW Severfield Structures Limited Option Agreement
7th Jul 20257:00 amRNSNotice of Results
4th Jun 20254:52 pmRNSTotal Voting Rights
22nd May 20257:00 amRNSHolding(s) in Company
25th Apr 20252:36 pmRNSDirector/PDMR Shareholding
24th Apr 20257:45 amRNS-RProgressive publishes new research
24th Apr 20257:00 amRNSPre-close trading update
1st Apr 20252:50 pmRNSBlock listing six monthly return
1st Apr 20252:06 pmRNSTotal Voting Rights
28th Mar 20258:15 amRNS-RProgressive publishes new research
26th Mar 20257:00 amRNSDirectorate Change
24th Mar 20259:36 amRNSChange in Director's Details Notification
3rd Mar 20257:01 amRNSShare Buyback Programme Cancellation
3rd Mar 20257:00 amRNSTrading Update
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20258:30 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20243:40 pmRNSHolding(s) in Company
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:20 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.